HIV Research Today is a free monthly online journal that collates and summarizes the latest research about HIV, including details on human immunodeficiency virus, testing, treatment, prevention, vaccines, aids.

Volume 3 (2006), Issue 1 (January)

1. Comparative pharmacogenomics of antiretroviral and cytotoxic treatments.
   Lancet Oncol, 7(1): 61-8. [Abstract] [Full-text]
2. C-reactive protein is a marker for human immunodeficiency virus disease progression.
   Arch Intern Med, 166(1): 64-70. [Abstract] [Full-text]
3. Depot-specific regulation of glucose uptake and insulin sensitivity in HIV-lipodystrophy.
   Am J Physiol Endocrinol Metab, 290(2): E289-98. [Abstract] [Full-text]
4. A new NMR solution structure of the SL1 HIV-1Lai loop-loop dimer.
   Nucleic Acids Res, 34(1): 343-52. [Abstract] [Full-text]
5. Stabilities of HIV-1 DIS type RNA loop-loop interactions in vitro and in vivo.
   Nucleic Acids Res, 34(1): 334-42. [Abstract] [Full-text]
6. Rapid expression of human immunodeficiency virus following activation of latently infected cells.
   J Virol, 80(3): 1599-603. [Abstract] [Full-text]
7. Characterization of antibody responses elicited by human immunodeficiency virus type 1 primary isolate trimeric and monomeric envelope glycoproteins in selected adjuvants.
   J Virol, 80(3): 1414-26. [Abstract] [Full-text]
8. Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef.
   J Virol, 80(3): 1311-20. [Abstract] [Full-text]
9. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.
   J Natl Cancer Inst, 98(2): 100-9. [Abstract] [Full-text]
10. Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection.
    Proc Natl Acad Sci U S A, 103(3): 738-43. [Abstract] [Full-text]
11. Two types of cytotoxic lymphocyte regulation explain kinetics of immune response to human immunodeficiency virus.
    Proc Natl Acad Sci U S A, 103(3): 666-71. [Abstract] [Full-text]
12. Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV.
    N Engl J Med, 354(3): 251-60. [Abstract] [Full-text]
13. Human immunodeficiency virus (HIV)-induced neurotoxicity: roles for the NMDA receptor subtypes.
    J Neurosci, 26(3): 981-90. [Abstract] [Full-text]
14. Rapid qualitative and quantitative analysis of T-cell responses in HIV-1-infected individuals receiving successful HAART and HIV-1 sero-negative controls: concomitant assessment of perforin, IFN-gamma and IL-4 secretion.
    J Immunol Methods, 308(1): 216-30. [Abstract] [Full-text]
15. Influence of the 2'-hydroxyl group conformation on the stability of A-form helices in RNA.
    J Mol Biol, 356(2): 280-7. [Abstract] [Full-text]
16. An immune control model for viral replication in the CNS during presymptomatic HIV infection.
    Brain, 129: 503-16. [Abstract] [Full-text]
17. APOBEC3F and APOBEC3G mRNA levels do not correlate with human immunodeficiency virus type 1 plasma viremia or CD4+ T-cell count.
    J Virol, 80(4): 2069-72. [Abstract] [Full-text]
18. Arsenic counteracts human immunodeficiency virus type 1 restriction by various TRIM5 orthologues in a cell type-dependent manner.
    J Virol, 80(4): 2051-4. [Abstract] [Full-text]
19. Human immunodeficiency virus fusion to dendritic cells declines as cells mature.
    J Virol, 80(4): 1992-9. [Abstract] [Full-text]
20. Human immunodeficiency virus type 1 incorporated with fusion proteins consisting of integrase and the designed polydactyl zinc finger protein E2C can bias integration of viral DNA into a predetermined chromosomal region in human cells.
    J Virol, 80(4): 1939-48. [Abstract] [Full-text]
21. Transient and stable knockdown of the integrase cofactor LEDGF/p75 reveals its role in the replication cycle of human immunodeficiency virus.
    J Virol, 80(4): 1886-96. [Abstract] [Full-text]
22. Novel Pol II fusion promoter directs human immunodeficiency virus type 1-inducible coexpression of a short hairpin RNA and protein.
    J Virol, 80(4): 1863-73. [Abstract] [Full-text]
23. CD4-specific transgenic expression of human cyclin T1 markedly increases human immunodeficiency virus type 1 (HIV-1) production by CD4+ T lymphocytes and myeloid cells in mice transgenic for a provirus encoding a monocyte-tropic HIV-1 isolate.
    J Virol, 80(4): 1850-62. [Abstract] [Full-text]
24. Modulation of cellular protein trafficking by human immunodeficiency virus type 1 Nef: role of the acidic residue in the ExxxLL motif.
    J Virol, 80(4): 1837-49. [Abstract] [Full-text]
25. Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines.
    J Virol, 80(4): 1762-72. [Abstract] [Full-text]
26. Structure-function analysis of the epitope for 4E10, a broadly neutralizing human immunodeficiency virus type 1 antibody.
    J Virol, 80(4): 1680-7. [Abstract] [Full-text]
27. Generation of CD8+ T-cell responses by a recombinant nonpathogenic Mycobacterium smegmatis vaccine vector expressing human immunodeficiency virus type 1 Env.
    J Virol, 80(4): 1645-52. [Abstract] [Full-text]
28. Human immunodeficiency virus type 1 env evolves toward ancestral states upon transmission to a new host.
    J Virol, 80(4): 1637-44. [Abstract] [Full-text]
29. Challenges in the concurrent management of malaria and HIV in pregnancy in sub-Saharan Africa.
    Lancet Infect Dis, 6(2): 100-11. [Abstract] [Full-text]
30. Vertically acquired paediatric coinfection with HIV and hepatitis C virus.
    Lancet Infect Dis, 6(2): 83-90. [Abstract] [Full-text]
31. Structural insights into the mechanisms of drug resistance in HIV-1 protease NL4-3.
    J Mol Biol, 356(4): 967-81. [Abstract] [Full-text]

© 2004-2008 HIV Research Today. All Rights Reserved.